RGEN
Repligen Corp
stockNASDAQ
At CloseOct 21, 2026 3:59:58 PM EDT
179.99USD+0.623%(+1.11)903,856
Pre-marketOct 21, 2026 8:49:30 AM EDT
174.00USD-2.728%(-4.88)
RGEN News
Repligen to Report Third Quarter 2026 Financial Results · 
GlobeNewswire Inc.
Why Freshworks Stock Bumped Higher Today · 
The Motley Fool
Why Freshworks Stock Bumped Higher Today · The Motley Fool
Repligen CEO Olivier Loeillot sells $1.03m of company stock · 
Investing.com
Repligen completes acquisition of BioLife Solutions · Investing.com
Repligen Completes Acquisition of BioLife Solutions · GlobeNewswire Inc.
Freshworks to Replace BioLife Solutions in S&P SmallCap 600 · 
Securities.io
Freshworks Set to Join S&P SmallCap 600 · 
PR Newswire
William Blair refreshes its analyst conviction list · 
Seeking Alpha
Repligen CEO Olivier Loeillot sells $976,680 in company stock · Investing.com
Repligen CEO Loeillot sells $2.46m in shares · Investing.com
Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS Studies · 
Zacks Investment Research
Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report? · Zacks Investment Research
GSK to Advance mRNA Influenza Vaccine Into Phase III Development · Zacks Investment Research
Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid · Zacks Investment Research
Why Is Repligen (RGEN) Up 27.7% Since Last Earnings Report? · Zacks Investment Research